Skip to content
56

Macular Degeneration Supplements

Worth a look

Shows low returns (0.0%), but a failed launch gate (market size, growth, or returns) keeps it on the watch list.

Market size 53Growth 56Conversion 96Competition 16Returns 100Price range 91Avg price 95Brand share 14Review moat 74Quality gap 32

Returns

Incredible0.0%

return rate — above 5% kills the launch gate

Conversion

Incredible14.3%

search→purchase rate — share of searches ending in a sale

Avg price

Incredible$29.40

avg listing price — sweet spot $15–$100

Price range

Great$12.73–$57.95

cheapest to priciest tracked listing — scored on the share inside $15–$100

Review moat

Good540.91

avg incumbent reviews — the moat a new listing must climb

Growth

Good+29.0%

90-day search growth — must beat 0% to launch

Market size

Good$353K

$353K/yr · 84K searches

Quality gap

Okay4.6★

avg incumbent rating — lower means beatable quality

Competition

Bad81%

top-5 click share — a locked-up shelf

Brand share

Bad95%

top-5 brand share — brand-locked demand

Is macular degeneration supplements profitable on Amazon?

According to Flapen's Amazon United States niche tracking, macular degeneration supplements is a $353K/yr Amazon United States market (84K searches/yr). The top 5 brands hold 95% of demand. Demand peaks in Jan–Mar–Oct–Nov–Dec. Verdict: Worth a look — 56/100.

Data updated Jul 25, 2026 · scored weekly · How we score niches

macular degeneration supplements market size & sales

Units sold, revenue, conversion and listing quality across the tracked shelf.
Units sold / yr
15K–20K
avg 1,500–2,000/product
Revenue / yr
$441K–$588K
units × avg price
Conversion rate
14.3%
Avg BSR
#175
Page quality
0%
Prime
91%
Sponsored
73%
Out of stock
0.0%
Avg brand age
67 months
Avg seller age
164 days

Competition: brands, sellers & click share

The top 5 products capture 81% of clicks — a locked-up shelf that new listings rarely crack.

Brands

7 rising

Sellers

18

Top-5 brand share

95%

Top 20: 100%

Top-5 click share

81%

Top 20: 100%

Open market

2%

  • Life Extension64%
  • Herbal Bee16%
  • Intelligent Formula7%
  • Simply Nature's Pledge5%
  • Nature's Fusions4%
  • Puritan's Pride3%
  • Open — no brand owns it (1 brand, 2%)

macular degeneration supplements demand & seasonality

Weekly Amazon search volume, last 100 weeks — +29.0% search growth over the last 90 days.
40K30KSpike '24Spike '25Prime Day '25Spike '26Prime Day '26DecMarJunAugNovMarMay

Peak months: Jan, Mar, Oct, Nov, Dec · busiest ÷ quietest = 7.4×

Top macular degeneration supplements search terms shoppers use

The exact queries shoppers type, with yearly volume, growth and conversion.
  • meso-zeaxanthin17K/yr
  • macuguard15K/yr
  • macuguard ocular support with saffron & astaxanthin10K/yr
  • life extension macuguard11K/yr
  • meso zeaxanthin7K/yr
  • meso-zeaxanthin eye supplement4K/yr
  • macuguard life extension10K/yr
  • lutein zeaxanthin meso-zeaxanthin3K/yr
  • life extension macuguard ocular support4K/yr
  • meso zeaxanthin supplements3K/yr
All search terms

Top macular degeneration supplements products & what they sell for

Every tracked product — its share of the shelf, its review moat, and what it sells for.

Each bubble is one product — market share against review moat; bubble size tracks estimated sales, color grades how beatable the incumbent looks.

0%10%$35K20%$71K30%$106K40%$141K1101001K10K Reviews — right = deep review moat Market share (90d) ≈ est. sales
Beatable (≤4.3★) Contested Strong incumbent (>4.7★)

All 11 tracked products in this niche — three views at once, no toggling.

What reviews say buyers love and hate about macular degeneration supplements

What buyers praise and complain about, mined from review topics.

What buyers love

Eye-Hygiene21%

“Happy with the product for vision support”

Quality-Overall13%

“A very good product fron a small business”

Ingredients-Overall10%

“The ingredient blend feels well-balanced and high quality”

Vitamin7%

“Great supplement”

Ease Of Chewing/Swallowing5%

“These capsules are easy to take”

Value For Money4%

“reasonably priced”

Efficiency3%

“Works well”

Focus Enhancement3%

“Comprehensive vision support”

Ease Of Use3%

“easy here”

Vegan/Organic3%

“I really like that the formula is vegan”

What buyers complain about

Value For Money9%

“They are quite pricey”

Ingredients-Overall7%

“A questionable ingredient”

Vitamin7%

“There is absolutely nothing in this supplement that I don't want in my body”

Size-Overall6%

“Gel caps are small”

Vision5%

“I haven't been using this product very long so I cannot give results on Improvement on my vision”

Visibility5%

“Ran out and noticed vision getting blurry and was having a harder time focusing on phone, etc”

Dosage5%

“I am just looking for the 10mg of Meso-zeaxanthin which is not readily available in all eye supplements”

Allergies3%

“DO NOT BUY THIS PRODUCT IF YOU HAVE ALLERGIES”

Instructions/User Manual/Troubleshooting3%

“Yet, no one can read the label including the directions”

Blood Sugar Level3%

“After purchasing this product i found out I can't use it because I take a blood thinner”

Top return reasons

Side Effects100%

Common macular degeneration supplements questions

Is macular degeneration supplements profitable to sell on Amazon United States?
The niche generates $353K/yr across 11 tracked products. 1 of 2 products launched in the last 360 days are still selling. 90-day search growth is +29.0%. Flapen's verdict: Worth a look (56/100).
How competitive is the macular degeneration supplements niche?
7 brands and 18 sellers compete. The top 5 products take 81% of clicks and top 5 brands hold 95% of demand.
What do buyers complain about in macular degeneration supplements?
Top complaints mined from reviews: Value For Money, Ingredients-Overall, Vitamin. The return rate is 0.0%.
When does demand for macular degeneration supplements peak?
Demand peaks in Jan–Mar–Oct–Nov–Dec; the busiest month runs 7.4× the quietest.
What does it cost to enter the macular degeneration supplements niche?
Listings span $12.73–$57.95; the average listing price is $29.40 (sweet spot $15–$100). The average incumbent carries 541 reviews — the moat a new listing must climb.